Cancer prevention with natural compounds

Seminars in Oncology

Volumn 37, Issue 3, 2010, Pages 258-281

  Gullett, Norleena P ^a   Ruhul Amin, A R M ^a   Bayraktar, Soley ^b   Pezzuto, John M ^c   Shin, Dong M ^a   Khuri, Fadlo R ^a   Aggarwal, Bharat B ^d   Surh, Young Joon ^e   Kucuk, Omer ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF HAWAII AT HILO   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; APIGENIN; BRASSININ; CURCUMIN; CURCUMINOID; ELLAGIC ACID; EMBELIN; EPICATECHIN; EPICATECHIN 3 GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; ERLOTINIB; FLUOROURACIL; GENISTEIN; GREEN TEA EXTRACT; HONOKIOL; ISOFLAVONE DERIVATIVE; LUPEOL; LUTEOLIN; LYCOPENE; NATURAL PRODUCT; OMEGA 3 FATTY ACID; PICEATANNOL; PLANT MEDICINAL PRODUCT; POMEGRANATE EXTRACT; QUERCETIN; RESVERATROL; SULFORAPHANE; THYMOQUINONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; BERRY; BROCCOLI; CABBAGE; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; CITRUS FRUIT; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG SAFETY; FRUIT; GARLIC; GINGER; HUMAN; MEDICINAL PLANT; NONHUMAN; ONION; POMEGRANATE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SOYBEAN; TEA; TOMATO; VEGETABLE; ANIMAL; FUNCTIONAL FOOD; NEOPLASMS; PHYTOTHERAPY;

ANIMALS; CHEMOPREVENTION; FUNCTIONAL FOOD; HUMANS; NEOPLASMS; PHYTOTHERAPY;

EID: 77956016499     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2010.06.014     Document Type: Article

References (326)

1. D.M. Eisenberg, R.B. Davis, and S.L. Ettner Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey JAMA 280 1998 1569 1575
2. V.L. Go, D.A. Wong, M.S. Resnick, and D. Heber Evaluation of botanicals and dietary supplements therapy in cancer patients J Nutr 131 2001 179S 180S
3. V.E. von Gruenigen, and M.P. Hopkins Alternative medicine in gynecologic oncology: a case report Gynecol Oncol 77 2000 190 192
4. J.M. Pezzuto Plant-derived anticancer agents Biochem Pharmacol 53 1997 121 133
5. P. Terry, F.B. Hu, H. Hansen, and A. Wolk Prospective study of major dietary patterns and colorectal cancer risk in women Am J Epidemiol 154 2001 1143 1149
6. M.A. Van Duyn, and E. Pivonka Overview of the health benefits of fruit and vegetable consumption for the dietetics professional: selected literature J Am Diet Assoc 100 2000 1511 1521
7. K.A. Steinmetz, and J.D. Potter Vegetables, fruit, and cancer prevention: a review J Am Diet Assoc 96 1996 1027 1039
8. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2008 CA Cancer J Clin 58 2008 71 96
9. M.J. Glade Food, nutrition, and the prevention of cancer: a global perspective American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997 Nutrition 15 1999 523 526
10. World Cancer Research Fund/American Institute for Cancer Research Food, nutrition, physical activity, and the prevention of cancer: a global perspective 2007 AICR Washington, DC
11. M. Wiseman The second World Cancer Research Fund/American Institute for Cancer Research expert report Food, nutrition, physical activity, and the prevention of cancer: a global perspective Proc Nutr Soc 67 2008 253 256
12. Y.C. Shih, and M.T. Halpern Economic evaluations of medical care interventions for cancer patients: how, why, and what does it mean? CA Cancer J Clin 58 2008 231 244
13. P.M. Barnes, B. Bloom, and R.L. Nahin Complementary and alternative medicine use among adults and children: United States, 2007 Natl Health Stat Report 2008 1 23
14. P.M. Barnes, E. Powell-Griner, K. McFann, and R.L. Nahin Complementary and alternative medicine use among adults: United States, 2002 Adv Data 2004 1 19
15. R.I. Haddad, and D.M. Shin Recent advances in head and neck cancer N Engl J Med 359 2008 1143 1154
16. S.M. Lippman Inaugural issue of Cancer Prevention Research Cancer Prev Res (Phila Pa) 1 2008 1 3
17. G.E. Goodman Assessing toxicity in cancer chemoprevention trials: the other side of the coin Cancer Prev Res (Phila Pa) 1 2008 499 502
18. D.L. Hatfield, and V.N. Gladyshev The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology Mol Interv 9 2009 18 21
19. E.A. Klein Selenium and vitamin E: interesting biology and dashed hope J Natl Cancer Inst 101 2009 283 285
20. W.K. Hong, J. Endicott, and L.M. Itri 13-cis-retinoic acid in the treatment of oral leukoplakia N Engl J Med 315 1986 1501 1505
21. S.M. Lippman, J.G. Batsakis, and B.B. Toth Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis N Engl J Med 328 1993 15 20
22. W.K. Hong, S.M. Lippman, and L.M. Itri Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck N Engl J Med 323 1990 795 801
23. S.E. Benner, T.F. Pajak, S.M. Lippman, C. Earley, and W.K. Hong Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up J Natl Cancer Inst 86 1994 140 141
24. U. Pastorino, G. Chiesa, and M. Infante Safety of high-dose vitamin A Randomized trial on lung cancer chemoprevention Oncology 48 1991 131 137
25. S.M. Lippman, J.J. Lee, and D.D. Karp Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer J Natl Cancer Inst 93 2001 605 618
26. F.R. Khuri, J.J. Lee, and S.M. Lippman Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients J Natl Cancer Inst 98 2006 441 450
27. D.M. Shin, F.R. Khuri, and B. Murphy Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial J Clin Oncol 19 2001 3010 3017
28. N. Arber, C.J. Eagle, and J. Spicak Celecoxib for the prevention of colorectal adenomatous polyps N Engl J Med 355 2006 885 895
29. F.R. Khuri, and V. Cohen Molecularly targeted approaches to the chemoprevention of lung cancer Clin Cancer Res 10 2004 4249s 4253s
30. Z. Zhang, Y. Wang, and L.E. Lantry Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf Oncogene 22 2003 6257 6265
31. M.S. Choe, X. Zhang, H.J. Shin, D.M. Shin, and Z.G. Chen Interaction between epidermal growth factor receptor- and cyclooxygenase 2-mediated pathways and its implications for the chemoprevention of head and neck cancer Mol Cancer Ther 4 2005 1448 1455
32. L. Reddy, B. Odhav, and K.D. Bhoola Natural products for cancer prevention: a global perspective Pharmacol Ther 99 2003 1 13
33. G. Block, B. Patterson, and A. Subar Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence Nutr Cancer 18 1992 1 29
34. V. Benetou, P. Orfanos, P. Lagiou, D. Trichopoulos, P. Boffetta, and A. Trichopoulou Vegetables and fruits in relation to cancer risk: evidence from the Greek EPIC cohort study Cancer Epidemiol Biomarkers Prev 17 2008 387 392
35. N.D. Freedman, Y. Park, and A.F. Subar Fruit and vegetable intake and head and neck cancer risk in a large United States prospective cohort study Int J Cancer 122 2008 2330 2336
36. Z.Y. Wang, M.T. Huang, and T. Ferraro Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice Cancer Res 52 1992 1162 1170
37. Y. Hara, S. Matsuzaki, and K. Nakamura Anti-tumor Activity of Tea Catechins Jpn Soc Nutr Food Sci 42 1989 39 45
38. J.D. Liu, S.H. Chen, C.L. Lin, S.H. Tsai, and Y.C. Liang Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3- gallate and dacarbazine in mice J Cell Biochem 83 2001 631 642
39. Y. Kuroda, and Y. Hara Antimutagenic and anticarcinogenic activity of tea polyphenols Mutat Res 436 1999 69 97
40. Y.D. Jung, and L.M. Ellis Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea Int J Exp Pathol 82 2001 309 316
41. Y. Cao, and R. Cao Angiogenesis inhibited by drinking tea Nature 398 1999 381
42. R.A. Goldbohm, M.G. Hertog, H.A. Brants, P.G. van, and P.A. van den Brandt Consumption of black tea and cancer risk: a prospective cohort study J Natl Cancer Inst 88 1996 93 100
43. W.J. Blot, W.H. Chow, and J.K. McLaughlin Tea and cancer: a review of the epidemiological evidence Eur J Cancer Prev 5 1996 425 438
44. C.S. Yang, and Z.Y. Wang Tea and cancer J Natl Cancer Inst 85 1993 1038 1049
45. L.K. Heilbrun, A. Nomura, and G.N. Stemmermann Black tea consumption and cancer risk: a prospective study Br J Cancer 54 1986 677 683
46. L.J. Kinlen, A.N. Willows, P. Goldblatt, and J. Yudkin Tea consumption and cancer Br J Cancer 58 1988 397 401
47. M. Inoue, K. Tajima, and M. Mizutani Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan Cancer Lett 167 2001 175 182
48. S. Muto, T. Yokoi, and Y. Gondo Inhibition of benzo[a]pyrene-induced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice Carcinogenesis 20 1999 421 424
49. T. Okuda, K. Mori, and H. Hayatsu Inhibitory effect of tannins on direct-acting mutagens Chem Pharm Bull (Tokyo) 32 1984 3755 3758
50. Y. Kuroda Bio-antimutagenic activity of green tea catechins in cultured Chinese hamster V79 cells Mutat Res 361 1996 179 186
51. Y.F. Sasaki, H. Yamada, K. Shimoi, K. Kator, and N. Kinae The clastogen-suppressing effects of green tea, Po-lei tea and Rooibos tea in CHO cells and mice Mutat Res 286 1993 221 232
52. M. Xu, A.C. Bailey, J.F. Hernaez, C.R. Taoka, H.A. Schut, and R.H. Dashwood Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat Carcinogenesis 17 1996 1429 1434
53. K. Komatsu, H. Tauchi, N. Yano, S. Endo, S. Matsuura, and S. Shoji Inhibitory action of (-)-epigallocatechin gallate on radiation-induced mouse oncogenic transformation Cancer Lett 112 1997 135 139
54. K. Komatsu, K. Kator, Y. Mitsuda, M. Mine, and Y. Okumura Inhibitory effects of Rooibos tea, Aspalathus linealis, on x-ray-induced C3H10T1/2 cell transformation Cancer Lett 77 1994 33 38
55. J. Terao, M. Piskula, and Q. Yao Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers Arch Biochem Biophys 308 1994 278 284
56. N. Ahmad, P. Cheng, and H. Mukhtar Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate Biochem Biophys Res Commun 275 2000 328 334
57. Y.C. Liang, S.Y. Lin-Shiau, C.F. Chen, and J.K. Lin Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate J Cell Biochem 75 1999 1 12
58. M. Liberto, and D. Cobrinik Growth factor-dependent induction of p21(CIP1) by the green tea polyphenol, epigallocatechin gallate Cancer Lett 154 2000 151 161
59. D.M. Smith, and Q.P. Dou Green tea polyphenol epigallocatechin inhibits DNA replication and consequently induces leukemia cell apoptosis Int J Mol Med 7 2001 645 652
60. N. Ahmad, D.K. Feyes, A.L. Nieminen, R. Agarwal, and H. Mukhtar Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells J Natl Cancer Inst 89 1997 1881 1886
61. J. Jankun, S.H. Selman, R. Swiercz, and E. Skrzypczak-Jankun Why drinking green tea could prevent cancer Nature 387 1997 561
62. S. Liao, Y. Umekita, J. Guo, J.M. Kokontis, and R.A. Hiipakka Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate Cancer Lett 96 1995 239 243
63. S. Gupta, N. Ahmad, A.L. Nieminen, and H. Mukhtar Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells Toxicol Appl Pharmacol 164 2000 82 90
64. S. Islam, N. Islam, and T. Kermode Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells Biochem Biophys Res Commun 270 2000 793 797
65. N. Ahmad, V.M. Adhami, S. Gupta, P. Cheng, and H. Mukhtar Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate Arch Biochem Biophys 398 2002 125 131
66. M.T. Huang, C.T. Ho, and Z.Y. Wang Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin Carcinogenesis 13 1992 947 954
67. S.G. Khan, S.K. Katiyar, R. Agarwal, and H. Mukhtar Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention Cancer Res 52 1992 4050 4052
68. J.K. Lin, Y.C. Liang, and S.Y. Lin-Shiau Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade Biochem Pharmacol 58 1999 911 915
69. M.J. Lee, Z.Y. Wang, and H. Li Analysis of plasma and urinary tea polyphenols in human subjects Cancer Epidemiol Biomarkers Prev 4 1995 393 399
70. T. Unno, K. Kondo, H. Itakura, and T. Takeo Analysis of (-)-epigallocatechin gallate in human serum obtained after ingesting green tea Biosci Biotechnol Biochem 60 1996 2066 2068
71. K. Nakagawa, S. Okuda, and T. Miyazawa Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma Biosci Biotechnol Biochem 61 1997 1981 1985
72. S. Nam, D.M. Smith, and Q.P. Dou Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo J Biol Chem 276 2001 13322 13330
73. K. Imai, K. Suga, and K. Nakachi Cancer-preventive effects of drinking green tea among a Japanese population Prev Med 26 1997 769 775
74. K. Nakachi, K. Suemasu, K. Suga, T. Takeo, K. Imai, and Y. Higashi Influence of drinking green tea on breast cancer malignancy among Japanese patients Jpn J Cancer Res 89 1998 254 261
75. L. Jian, L.P. Xie, A.H. Lee, and C.W. Binns Protective effect of green tea against prostate cancer: a case-control study in southeast China Int J Cancer 108 2004 130 135
76. A.H. Wu, M.C. Yu, C.C. Tseng, J. Hankin, and M.C. Pike Green tea and risk of breast cancer in Asian Americans Int J Cancer 106 2003 574 579
77. N. Khan, F. Afaq, and H. Mukhtar Cancer chemoprevention through dietary antioxidants: progress and promise Antioxid Redox Signal 10 2008 475 510
78. J.L. Bushman Green tea and cancer in humans: a review of the literature Nutr Cancer 31 1998 151 159
79. M.S. Baliga, S. Meleth, and S.K. Katiyar Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems Clin Cancer Res 11 2005 1918 1927
80. M.R. Sartippour, D. Heber, J. Ma, Q. Lu, V.L. Go, and M. Nguyen Green tea and its catechins inhibit breast cancer xenografts Nutr Cancer 40 2001 149 156
81. H. Xiao, X. Hao, and B. Simi Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats Carcinogenesis 29 2008 113 119
82. Y.T. Gao, J.K. McLaughlin, W.J. Blot, B.T. Ji, Q. Dai, and J.F. Fraumeni Jr Reduced risk of esophageal cancer associated with green tea consumption J Natl Cancer Inst 86 1994 855 858
83. T.D. Shanafelt, Y.K. Lee, and T.G. Call Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies Leuk Res 30 2006 707 712
84. C.S. Yang, L. Chen, M.J. Lee, D. Balentine, M.C. Kuo, and S.P. Schantz Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers Cancer Epidemiol Biomarkers Prev 7 1998 351 354
85. H.H. Chow, Y. Cai, and D.S. Alberts Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E Cancer Epidemiol Biomarkers Prev 10 2001 53 58
86. H.H. Chow, Y. Cai, and I.A. Hakim Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals Clin Cancer Res 9 2003 3312 3319
87. K.M. Pisters, R.A. Newman, and B. Coldman Phase I trial of oral green tea extract in adult patients with solid tumors J Clin Oncol 19 2001 1830 1838
88. X. Zhang, H. Zhang, and M. Tighiouart Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor Int J Cancer 123 2008 1005 1014
89. I.A. Siddiqui, A. Malik, and V.M. Adhami Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis Oncogene 27 2008 2055 2063
90. Y.J. Surh, and K.S. Chun Cancer chemopreventive effects of curcumin Adv Exp Med Biol 595 2007 149 172
91. R. Kuttan, P. Bhanumathy, K. Nirmala, and M.C. George Potential anticancer activity of turmeric (Curcuma longa) Cancer Lett 29 1985 197 202
92. R. Kuttan, P.C. Sudheeran, and C.D. Josph Turmeric and curcumin as topical agents in cancer therapy Tumori 73 1987 29 31
93. Clinical development plan: curcumin J Cell Biochem Suppl 26 1996 72 85
94. C.V. Rao, A. Rivenson, B. Simi, and B.S. Reddy Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound Cancer Res 55 1995 259 266
95. M.T. Huang, Y.R. Lou, W. Ma, H.L. Newmark, K.R. Reuhl, and A.H. Conney Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice Cancer Res 54 1994 5841 5847
96. T. Kawamori, R. Lubet, and V.E. Steele Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer Cancer Res 59 1999 597 601
97. A.H. Conney Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture Cancer Res 63 2003 7005 7031
98. N. Li, X. Chen, and J. Liao Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin Carcinogenesis 23 2002 1307 1313
99. M. Li, Z. Zhang, D.L. Hill, H. Wang, and R. Zhang Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway Cancer Res 67 2007 1988 1996
100. G. Kuttan, K.B. Kumar, C. Guruvayoorappan, and R. Kuttan Antitumor, anti-invasion, and antimetastatic effects of curcumin Adv Exp Med Biol 595 2007 173 184
101. S.P. Verma, E. Salamone, and B. Goldin Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides Biochem Biophys Res Commun 233 1997 692 696
102. A. Khafif, S.P. Schantz, T.C. Chou, D. Edelstein, and P.G. Sacks Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells Carcinogenesis 19 1998 419 424
103. M. Sreepriya, and G. Bali Effects of administration of Embelin and Curcumin on lipid peroxidation, hepatic glutathione antioxidant defense and hematopoietic system during N-nitrosodiethylamine/Phenobarbital-induced hepatocarcinogenesis in Wistar rats Mol Cell Biochem 284 2006 49 55
104. J.Y. Koo, H.J. Kim, K.O. Jung, and K.Y. Park Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil J Med Food 7 2004 117 121
105. A.B. Kunnumakkara, S. Guha, S. Krishnan, P. Diagaradjane, J. Gelovani, and B.B. Aggarwal Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products Cancer Res 67 2007 3853 3861
106. S. Sen, H. Sharma, and N. Singh Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway Biochem Biophys Res Commun 331 2005 1245 1252
107. M. Cruz-Correa, D.A. Shoskes, and P. Sanchez Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis Clin Gastroenterol Hepatol 4 2006 1035 1038
108. A.L. Cheng, C.H. Hsu, and J.K. Lin Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Res 21 2001 2895 2900
109. R.A. Sharma, H.R. McLelland, and K.A. Hill Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer Clin Cancer Res 7 2001 1894 1900
110. J.M. Pezzuto Resveratrol as an inhibitor of carcinogenesis Pharm Biol 46 2008 443 573
111. M.H. Aziz, S. Reagan-Shaw, J. Wu, B.J. Longley, and N. Ahmad Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J 19 2005 1193 1195
112. S. Banerjee, C. Bueso-Ramos, and B.B. Aggarwal Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9 Cancer Res 62 2002 4945 4954
113. M. Jang, L. Cai, and G.O. Udeani Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
114. M. Sengottuvelan, and N. Nalini Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development Br J Nutr 96 2006 145 153
115. Y.-J. Surh, and J.K. Kundu Resveratrol as an anti-inflammatory agent B.B. Aggarwal, S. Shishodia, Resveratrol in health and diseases 2005 CRC Press Boca Raton, FL 601 608
116. B. Djoko, R.Y. Chiou, J.J. Shee, and Y.W. Liu Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages J Agric Food Chem 55 2007 2376 2383
117. S. Islam, F. Hassan, and M.M. Mu Piceatannol prevents lipopolysaccharide (LPS)-induced nitric oxide (NO) production and nuclear factor (NF)-kappaB activation by inhibiting IkappaB kinase (IKK) Microbiol Immunol 48 2004 729 736
118. C.Y. Jin, D.O. Moon, and K.J. Lee Piceatannol attenuates lipopolysaccharide-induced NF-kappaB activation and NF-kappaB-related proinflammatory mediators in BV2 microglia Pharmacol Res 54 2006 461 467
119. H. Matsuda, T. Kageura, T. Morikawa, I. Toguchida, S. Harima, and M. Yoshikawa Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages Bioorg Med Chem Lett 10 2000 323 327
120. P. Waffo-Teguo, M.E. Hawthorne, and M. Cuendet Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures Nutr Cancer 40 2001 173 179
121. M. Athar, J.H. Back, and X. Tang Resveratrol: a review of preclinical studies for human cancer prevention Toxicol Appl Pharmacol 224 2007 274 283
122. Z.G. Li, T. Hong, and Y. Shimada Suppression of N- nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol Carcinogenesis 23 2002 1531 1536
123. S. Garvin, K. Ollinger, and C. Dabrosin Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo Cancer Lett 231 2006 113 122
124. C. Gill, S.E. Walsh, C. Morrissey, J.M. Fitzpatrick, and R.W. Watson Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms Prostate 67 2007 1641 1653
125. B.A. Narayanan, N.K. Narayanan, G.G. Re, and D.W. Nixon Differential expression of genes induced by resveratrol in LNCaP cells: p53-mediated molecular targets Int J Cancer 104 2003 204 212
126. M.H. Aziz, M. Nihal, V.X. Fu, D.F. Jarrard, and N. Ahmad Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins Mol Cancer Ther 5 2006 1335 1341
127. X. Ma, X. Tian, X. Huang, F. Yan, and D. Qiao Resveratrol-induced mitochondrial dysfunction and apoptosis are associated with Ca2+ and mCICR-mediated MPT activation in HepG2 cells Mol Cell Biochem 302 2007 99 109
128. Z.J. Sun, C.E. Pan, H.S. Liu, and G.J. Wang Anti-hepatoma activity of resveratrol in vitro World J Gastroenterol 8 2002 79 81
129. N. Carbo, P. Costelli, F.M. Baccino, F.J. Lopez-Soriano, and J.M. Argiles Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model Biochem Biophys Res Commun 254 1999 739 743
130. X.Z. Ding, and T.E. Adrian Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells Pancreas 25 2002 e71 e76
131. T. Kubota, Y. Uemura, M. Kobayashi, and H. Taguchi Combined effects of resveratrol and paclitaxel on lung cancer cells Anticancer Res 23 2003 4039 4046
132. S.L. Wu, Z.J. Sun, L. Yu, K.W. Meng, X.L. Qin, and C.E. Pan Effect of resveratrol and in combination with 5-FU on murine liver cancer World J Gastroenterol 10 2004 3048 3052
133. A. Revel, H. Raanani, and E. Younglai Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene J Appl Toxicol 23 2003 255 261
134. D.J. Boocock, G.E. Faust, and K.R. Patel Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent Cancer Epidemiol Biomarkers Prev 16 2007 1246 1252
135. E. Giovannucci Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature J Natl Cancer Inst 91 1999 317 331
136. S. Seren, R. Lieberman, and U.D. Bayraktar Lycopene in cancer prevention and treatment Am J Ther 15 2008 66 81
137. S. Franceschi, E. Bidoli, V.C. La, R. Talamini, B. D'Avanzo, and E. Negri Tomatoes and risk of digestive-tract cancers Int J Cancer 59 1994 181 184
138. E. Giovannucci, E.B. Rimm, Y. Liu, M.J. Stampfer, and W.C. Willett A prospective study of tomato products, lycopene, and prostate cancer risk J Natl Cancer Inst 94 2002 391 398
139. R. Garcia-Closas, X. Castellsague, X. Bosch, and C.A. Gonzalez The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence Int J Cancer 117 2005 629 637
140. S. Schwarz, U.C. Obermuller-Jevic, E. Hellmis, W. Koch, G. Jacobi, and H.K. Biesalski Lycopene inhibits disease progression in patients with benign prostate hyperplasia J Nutr 138 2008 49 53
141. H.S. Kim, P. Bowen, and L. Chen Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma Nutr Cancer 47 2003 40 47
142. V. Venkateswaran, N.E. Fleshner, L.M. Sugar, and L.H. Klotz Antioxidants block prostate cancer in lady transgenic mice Cancer Res 64 2004 5891 5896
143. K. Canene-Adams, B.L. Lindshield, S. Wang, E.H. Jeffery, S.K. Clinton, and J.W. Erdman Jr Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas Cancer Res 67 2007 836 843
144. O. Kucuk, F.H. Sarkar, and W. Sakr Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy Cancer Epidemiol Biomarkers Prev 10 2001 861 868
145. U. Vaishampayan, M. Hussain, and M. Banerjee Lycopene and soy isoflavones in the treatment of prostate cancer Nutr Cancer 59 2007 1 7
146. A.H. Wang, and L.S. Zhang [Effect of lycopene on the proliferation of MCF-7 and MDA-MB-231 cells] Sichuan Da Xue Xue Bao Yi Xue Ban 38 2007 958 960 976
147. F. Fornelli, A. Leone, I. Verdesca, F. Minervini, and G. Zacheo The influence of lycopene on the proliferation of human breast cell line (MCF-7) Toxicol In Vitro 21 2007 217 223
148. L. Tang, T. Jin, X. Zeng, and J.S. Wang Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice J Nutr 135 2005 287 290
149. A. Sengupta, S. Ghosh, R.K. Das, S. Bhattacharjee, and S. Bhattacharya Chemopreventive potential of diallylsulfide, lycopene and theaflavin during chemically induced colon carcinogenesis in rat colon through modulation of cyclooxygenase-2 and inducible nitric oxide synthase pathways Eur J Cancer Prev 15 2006 301 305
150. J. Levy, E. Bosin, and B. Feldman Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene Nutr Cancer 24 1995 257 266
151. D.J. Kim, N. Takasuka, and J.M. Kim Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH Cancer Lett 120 1997 15 22
152. D.J. Kim, N. Takasuka, H. Nishino, and H. Tsuda Chemoprevention of lung cancer by lycopene Biofactors 13 2000 95 102
153. D.S. Michaud, D. Feskanich, and E.B. Rimm Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts Am J Clin Nutr 72 2000 990 997
154. K. Sahin, R. Ozercan, and M. Onderci Lycopene supplementation prevents the development of spontaneous smooth muscle tumors of the oviduct in Japanese quail Nutr Cancer 50 2004 181 189
155. R. Longtin The pomegranate: nature's power fruit? J Natl Cancer Inst 95 2003 346 348
156. S.Y. Schubert, E.P. Lansky, and I. Neeman Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids J Ethnopharmacol 66 1999 11 17
157. M.I. Gil, F.A. Tomas-Barberan, B. Hess-Pierce, D.M. Holcroft, and A.A. Kader Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing J Agric Food Chem 48 2000 4581 4589
158. Y. Noda, T. Kaneyuki, A. Mori, and L. Packer Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin J Agric Food Chem 50 2002 166 171
159. N.D. Kim, R. Mehta, and W. Yu Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer Breast Cancer Res Treat 71 2002 203 217
160. M. Toi, H. Bando, and C. Ramachandran Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo Angiogenesis 6 2003 121 128
161. Y. Zhang, S.K. Vareed, and M.G. Nair Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables Life Sci 76 2005 1465 1472
162. J.J. Hora, E.R. Maydew, E.P. Lansky, and C. Dwivedi Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice J Med Food 6 2003 157 161
163. N. Khan, N. Hadi, F. Afaq, D.N. Syed, M.H. Kweon, and H. Mukhtar Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice Carcinogenesis 28 2007 163 173
164. N. Khan, F. Afaq, M.H. Kweon, K. Kim, and H. Mukhtar Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice Cancer Res 67 2007 3475 3482
165. A. Malik, F. Afaq, S. Sarfaraz, V.M. Adhami, D.N. Syed, and H. Mukhtar Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer Proc Natl Acad Sci U S A 102 2005 14813 14818
166. M.R. Sartippour, N.P. Seeram, and J.Y. Rao Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo Int J Oncol 32 2008 475 480
167. A.J. Pantuck, J.T. Leppert, and N. Zomorodian Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer Clin Cancer Res 12 2006 4018 4026
168. K. Shimoi, N. Saka, K. Kaji, R. Nozawa, and N. Kinae Metabolic fate of luteolin and its functional activity at focal site Biofactors 12 2000 181 186
169. S.F. Yang, W.E. Yang, H.R. Chang, S.C. Chu, and Y.S. Hsieh Luteolin induces apoptosis in oral squamous cancer cells J Dent Res 87 2008 401 406
170. Q. Zhang, X.H. Zhao, and Z.J. Wang Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis Food Chem Toxicol 46 2008 2042 2053
171. W. Ju, X. Wang, H. Shi, W. Chen, S.A. Belinsky, and Y. Lin A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells Mol Pharmacol 71 2007 1381 1388
172. d.Y. Lim, Y. Jeong, A.L. Tyner, and J.H. Park Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin Am J Physiol Gastrointest Liver Physiol 292 2007 G66 G75
173. K. Selvendiran, H. Koga, and T. Ueno Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids Cancer Res 66 2006 4826 4834
174. F.L. Chiu, and J.K. Lin Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts Prostate 68 2008 61 71
175. B. Wu, Q. Zhang, W. Shen, and J. Zhu Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line Mol Cell Biochem 313 2008 125 132
176. R.P. Samy, P. Gopalakrishnakone, and S. Ignacimuthu Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats Chem Biol Interact 164 2006 1 14
177. V. Manju, and N. Nalini Protective role of luteolin in 1,2-dimethylhydrazine induced experimental colon carcinogenesis Cell Biochem Funct 25 2007 189 194
178. A. Atmaca, M. Kleerekoper, M. Bayraktar, and O. Kucuk Soy isoflavones in the management of postmenopausal osteoporosis Menopause 15 2008 748 757
179. J.R. Hebert, T.G. Hurley, B.C. Olendzki, J. Teas, Y. Ma, and J.S. Hampl Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study J Natl Cancer Inst 90 1998 1637 1647
180. H. Adlercreutz, H. Honjo, and A. Higashi Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet Am J Clin Nutr 54 1991 1093 1100
181. R.G. Ziegler, R.N. Hoover, and M.C. Pike Migration patterns and breast cancer risk in Asian-American women J Natl Cancer Inst 85 1993 1819 1827
182. M.T. Goodman, L.R. Wilkens, J.H. Hankin, L.C. Lyu, A.H. Wu, and L.N. Kolonel Association of soy and fiber consumption with the risk of endometrial cancer Am J Epidemiol 146 1997 294 306
183. L. Hilakivi-Clarke, I. Onojafe, and M. Raygada Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis Br J Cancer 80 1999 1682 1688
184. M. Onozawa, T. Kawamori, and M. Baba Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats Jpn J Cancer Res 90 1999 393 398
185. M. Lakshman, L. Xu, and V. Ananthanarayanan Dietary genistein inhibits metastasis of human prostate cancer in mice Cancer Res 68 2008 2024 2032
186. Y. Wang, J.J. Raffoul, and M. Che Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model Radiat Res 166 2006 73 80
187. R.M. Mohammad, S. Banerjee, Y. Li, A. Aboukameel, O. Kucuk, and F.H. Sarkar Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts Cancer 106 2006 1260 1268
188. M. Hussain, M. Banerjee, and F.H. Sarkar Soy isoflavones in the treatment of prostate cancer Nutr Cancer 47 2003 111 117
189. J.M. Pendleton, W.W. Tan, and S. Anai Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy BMC Cancer 8 2008 132
190. Y. Li, M. Che, and S. Bhagat Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein Neoplasia 6 2004 354 363
191. F.H. Sarkar, and Y. Li The role of isoflavones in cancer chemoprevention Front Biosci 9 2004 2714 2724
192. J.R. Zhou, E.T. Gugger, T. Tanaka, Y. Guo, G.L. Blackburn, and S.K. Clinton Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice J Nutr 129 1999 1628 1635
193. Y. Li, O. Kucuk, M. Hussain, J. Abrams, M.L. Cher, and F.H. Sarkar Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer Cancer Res 66 2006 4816 4825
194. G.G. Hillman, J.D. Forman, and O. Kucuk Genistein potentiates the radiation effect on prostate carcinoma cells Clin Cancer Res 7 2001 382 390
195. J.J. Raffoul, Y. Wang, O. Kucuk, J.D. Forman, F.H. Sarkar, and G.G. Hillman Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest BMC Cancer 6 2006 107
196. J.J. Raffoul, S. Banerjee, and V. Singh-Gupta Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo Cancer Res 67 2007 2141 2149
197. G.G. Hillman, Y. Wang, and O. Kucuk Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model Mol Cancer Ther 3 2004 1271 1279
198. J.J. Raffoul, S. Banerjee, and M. Che Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model Int J Cancer 120 2007 2491 2498
199. Z. Djuric, G. Chen, D.R. Doerge, L.K. Heilbrun, and O. Kucuk Effect of soy isoflavone supplementation on markers of oxidative stress in men and women Cancer Lett 172 2001 1 6
200. J.N. Davis, O. Kucuk, Z. Djuric, and F.H. Sarkar Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes Free Radic Biol Med 30 2001 1293 1302
201. J.N. Davis, O. Kucuk, and F.H. Sarkar Genistein inhibits NF-kappa B activation in prostate cancer cells Nutr Cancer 35 1999 167 174
202. M. Blay, A.E. Espinel, and M.A. Delgado Isoflavone effect on gene expression profile and biomarkers of inflammation J Pharm Biomed Anal 51 2010 382 390
203. Ahmad I, Forman J, Sarkar FH. Soy isofalvons in conjunction with radiation therapy in patients with prostate cancer. Nutr Cancer. In press.
204. Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem. In press.
205. P.J. Gillies Preemptive nutrition of pro-inflammatory states: a nutrigenomic model Nutr Rev 65 2007 S217 S220
206. R.A. Karmali Historical perspective and potential use of n-3 fatty acids in therapy of cancer cachexia Nutrition 12 1996 S2 S4
207. S.N. Meydani, and C.A. Dinarello Influence of dietary fatty acids on cytokine production and its clinical implications Nutr Clin Pract 8 1993 65 72
208. S. Endres, S.N. Meydani, R. Ghorbani, R. Schindler, and C.A. Dinarello Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation J Leukoc Biol 54 1993 599 603
209. M.J. Tisdale Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia Nutrition 12 1996 S31 S33
210. I.M. Berquin, I.J. Edwards, and Y.Q. Chen Multi-targeted therapy of cancer by omega-3 fatty acids Cancer Lett 269 2008 363 377
211. C.P. Burns, S. Halabi, and G. Clamon Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia Cancer 101 2004 370 378
212. N.K. Narayanan, B.A. Narayanan, and B.S. Reddy A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors Int J Oncol 26 2005 785 792
213. S. Banerjee, A.O. Kaseb, and Z. Wang Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer Cancer Res 69 2009 5575 5583
214. H.U. Gali-Muhtasib, W.G. Abou Kheir, L.A. Kheir, N. Darwiche, and P.A. Crooks Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes Anticancer Drugs 15 2004 389 399
215. N. Chehl, G. Chipitsyna, Q. Gong, C.J. Yeo, and H.A. Arafat Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells HPB (Oxford) 11 2009 373 381
216. H. Gali-Muhtasib, M. Ocker, and D. Kuester Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models J Cell Mol Med 12 2008 330 342
217. D. Al-Johar, N. Shinwari, and J. Arif Role of Nigella sativa and a number of its antioxidant constituents towards azoxymethane-induced genotoxic effects and colon cancer in rats Phytother Res 22 2008 1311 1323
218. A.O. Kaseb, K. Chinnakannu, and D. Chen Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer Cancer Res 67 2007 7782 7788
219. J.S. Jurenka Therapeutic applications of pomegranate (Punica granatum L.): a review Altern Med Rev 13 2008 128 144
220. D. Heber Multitargeted therapy of cancer by ellagitannins Cancer Lett 269 2008 262 268
221. P.K. Chaturvedi, K. Bhui, and Y. Shukla Lupeol: connotations for chemoprevention Cancer Lett 263 2008 1 13
222. R.H. Cichewicz, and S.A. Kouzi Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection Med Res Rev 24 2004 90 114
223. B. Ye, M. Aponte, and Y. Dai Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence Cancer Lett 251 2007 43 52
224. F.V. DeFeudis, V. Papadopoulos, and K. Drieu Ginkgo biloba extracts and cancer: a research area in its infancy Fundam Clin Pharmacol 17 2003 405 417
225. S.K. Mencher, and L.G. Wang Promiscuous drugs compared to selective drugs (promiscuity can be a virtue) BMC Clin Pharmacol 5 2005 3
226. B.B. Aggarwal, R.V. Vijayalekshmi, and B. Sung Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe Clin Cancer Res 15 2009 425 430
227. B.B. Aggarwal, A.B. Kunnumakkara, and K.B. Harikumar Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 1171 2009 59 76
228. K.S. Ahn, and B.B. Aggarwal Transcription factor NF-κB: a sensor for smoke and stress signals Ann N Y Acad Sci 1056 2005 218 233
229. G. Sethi, B. Sung, and B.B. Aggarwal TNF: a master switch for inflammation to cancer Front Biosci 13 2008 5094 5107
230. S. Luqman, and J.M. Pezzuto NF-kappaB: A promising target for natural products in cancer chemoprevention Phytother Res 24 2010 949 963
231. J. Ravindran, S. Prasad, and B.B. Aggarwal Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11 2009 495 510
232. S.K. Sandur, A. Deorukhkar, and M.K. Pandey Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity Int J Radiat Oncol Biol Phys 75 2009 534 542
233. A.B. Kunnumakkara, P. Diagaradjane, and P. Anand Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model Int J Cancer 125 2009 2187 2197
234. E. Appella, and C.W. Anderson Post-translational modifications and activation of p53 by genotoxic stresses Eur J Biochem 268 2001 2764 2772
235. A.M. Bode, and Z. Dong Post-translational modification of p53 in tumorigenesis Nat Rev Cancer 4 2004 793 805
236. A.M. Carr Cell cycle Piecing together the p53 puzzle Science 287 2000 1765 1766
237. C.J. Sherr, and J.D. Weber The ARF/p53 pathway Curr Opin Genet Dev 10 2000 94 99
238. L.J. Ko, and C. Prives p53: puzzle and paradigm Genes Dev 10 1996 1054 1072
239. M.K. Agarwal, A.R. Ruhul Amin, and M.L. Agarwal DNA replication licensing factor minichromosome maintenance deficient 5 rescues p53-mediated growth arrest Cancer Res 67 2007 116 121
240. J.S. Ho, W. Ma, D.Y. Mao, and S. Benchimol p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest Mol Cell Biol 25 2005 7423 7431
241. K. Hastak, M.K. Agarwal, H. Mukhtar, and M.L. Agarwal Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate FASEB J 19 2005 789 791
242. A.M. Roy, M.S. Baliga, and S.K. Katiyar Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation Mol Cancer Ther 4 2005 81 90
243. V.S. Thakur, A.R. Ruhul Amin, and R.K. Paul p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG Cancer Lett 2010 Epub ahead of print
244. T. Choudhuri, S. Pal, M.L. Agwarwal, T. Das, and G. Sa Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction FEBS Lett 512 2002 334 340
245. B. Tian, Z. Wang, and Y. Zhao Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model Cancer Lett 264 2008 299 308
246. S. Shankar, and R.K. Srivastava Involvement of Bcl-2 family members, phosphatidylinositol 3′-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer Int J Oncol 30 2007 905 918
247. C. Huang, W.Y. Ma, A. Goranson, and Z. Dong Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway Carcinogenesis 20 1999 237 242
248. S. Shankar, I. Siddiqui, and R.K. Srivastava Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells Mol Cell Biochem 304 2007 273 285
249. F. Schmidt, C.B. Knobbe, B. Frank, H. Wolburg, and M. Weller The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines Oncol Rep 19 2008 1061 1066
250. M. Kaghad, H. Bonnet, and A. Yang Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 90 1997 809 819
251. A. Yang, M. Kaghad, and Y. Wang p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Mol Cell 2 1998 305 316
252. A.R. Amin, V.S. Thakur, and R.K. Paul SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG Proc Natl Acad Sci U S A 104 2007 5419 5424
253. M.A. Shammas, P. Neri, and H. Koley Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications Blood 108 2006 2804 2810
254. B.B. Aggarwal Nuclear factor-kappaB: the enemy within Cancer Cell 6 2004 203 208
255. S. Singh, and B.B. Aggarwal Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected] J Biol Chem 270 1995 24995 25000
256. A.L. Kasinski, Y. Du, and S.L. Thomas Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene) piperidin-4-one (EF24), a novel monoketone analog of curcumin Mol Pharmacol 74 2008 654 661
257. S.K. Manna, A. Mukhopadhyay, and B.B. Aggarwal Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation J Immunol 164 2000 6509 6519
258. K. Hastak, S. Gupta, N. Ahmad, M.K. Agarwal, M.L. Agarwal, and H. Mukhtar Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells Oncogene 22 2003 4851 4859
259. G.Y. Kim, J.H. Kim, and S.C. Ahn Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB Immunology 113 2004 203 211
260. E. Shaulian, and M. Karin AP-1 as a regulator of cell life and death Nat Cell Biol 4 2002 E131 E136
261. H.S. Kim, M.H. Kim, and M. Jeong EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells Anticancer Res 24 2004 747 753
262. J.K. Kundu, Y.K. Shin, and Y.J. Surh Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets Biochem Pharmacol 72 2006 1506 1515
263. K.M. Dhandapani, V.B. Mahesh, and D.W. Brann Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors J Neurochem 102 2007 522 538
264. M. Shimizu, A. Deguchi, A.K. Joe, J.F. Mckoy, H. Moriwaki, and I.B. Weinstein EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells J Exp Ther Oncol 5 2005 69 78
265. J.E. Darnell Jr, I.M. Kerr, and G.R. Stark Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421
266. J.R. Grandis, S.D. Drenning, and A. Chakraborty Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth In vitro J Clin Invest 102 1998 1385 1392
267. H. Leong, P.S. Mathur, and G.L. Greene Green tea catechins inhibit angiogenesis through suppression of STAT3 activation Breast Cancer Res Treat 117 2009 505 515
268. B.S. Wung, M.C. Hsu, C.C. Wu, and C.W. Hsieh Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation Life Sci 78 2005 389 397
269. E.K. Kim, K.B. Kwon, and M.Y. Song Genistein protects pancreatic beta cells against cytokine-mediated toxicity Mol Cell Endocrinol 278 2007 18 28
270. A.C. Bharti, N. Donato, and B.B. Aggarwal Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells J Immunol 171 2003 3863 3871
271. I.A. Siddiqui, Y. Shukla, and V.M. Adhami Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model Pharm Res 25 2008 2135 2142
272. S. Bhattacharyya, D. Mandal, B. Saha, G.S. Sen, T. Das, and G. Sa Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction J Biol Chem 282 2007 15954 15964
273. Q.P. Dou Molecular mechanisms of green tea polyphenols Nutr Cancer 61 2009 827 835
274. L. Korutla, J.Y. Cheung, J. Mendelsohn, and R. Kumar Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin Carcinogenesis 16 1995 1741 1745
275. B.B. Patel, R. Sengupta, and S. Qazi Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R Int J Cancer 122 2008 267 273
276. M. Masuda, M. Suzui, and I.B. Weinstein Effects of epigallocatechin-3- gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines Clin Cancer Res 7 2001 4220 4229
277. M. Shimizu, A. Deguchi, Y. Hara, H. Moriwaki, and I.B. Weinstein EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells Biochem Biophys Res Commun 334 2005 947 953
278. S. Adachi, T. Nagao, and H.I. Ingolfsson The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells Cancer Res 67 2007 6493 6501
279. J. Fang, Q. Zhou, X.L. Shi, and B.H. Jiang Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells Carcinogenesis 28 2007 713 723
280. L.T. Lee, Y.T. Huang, and J.J. Hwang Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells Anticancer Res 22 2002 1615 1627
281. G.P. Dunn, L.J. Old, and R.D. Schreiber The immunobiology of cancer immunosurveillance and immunoediting Immunity 21 2004 137 148
282. S.M. Meeran, S.K. Mantena, C.A. Elmets, and S.K. Katiyar (-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair Cancer Res 66 2006 5512 5520
283. S.K. Mantena, A.M. Roy, and S.K. Katiyar Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors Photochem Photobiol 81 2005 1174 1179
284. T.H. Kang, J.H. Lee, and C.K. Song Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination Cancer Res 67 2007 802 811
285. T.L. Guo, J.A. McCay, and L.X. Zhang Genistein modulates immune responses and increases host resistance to B16F10 tumor in adult female B6C3F1 mice J Nutr 131 2001 3251 3258
286. Y. Yang, J.H. Paik, D. Cho, J.A. Cho, and C.W. Kim Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells Int Immunopharmacol 8 2008 542 547
287. S. Shankar, S. Ganapathy, S.R. Hingorani, and R.K. Srivastava EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer Front Biosci 13 2008 440 452
288. E. Bagli, M. Stefaniotou, and L. Morbidelli Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity Cancer Res 64 2004 7936 7946
289. Y.G. Lin, A.B. Kunnumakkara, and A. Nair Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway Clin Cancer Res 13 2007 3423 3430
290. A.E. Gururaj, M. Belakavadi, D.A. Venkatesh, D. Marme, and B.P. Salimath Molecular mechanisms of anti-angiogenic effect of curcumin Biochem Biophys Res Commun 297 2002 934 942
291. Y. Guo, S. Wang, D.R. Hoot, and S.K. Clinton Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones J Nutr Biochem 18 2007 408 417
292. R. Schindler, and R. Mentlein Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells J Nutr 136 2006 1477 1482
293. A. Melhem, M. Stern, and O. Shibolet Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial J Clin Gastroenterol 39 2005 737 742
294. A. von Herbay, W. Stahl, C. Niederau, and H. Sies Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study Free Radic Res 27 1997 599 605
295. A.M. Di Bisceglie, A.C. Lyra, and M. Schwartz Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status Am J Gastroenterol 98 2003 2060 2063
296. K. Ikeda, S. Saitoh, and Y. Suzuki Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients J Hepatol 28 1998 930 938
297. H. Takagi, S. Kakizaki, and N. Sohara Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis Int J Vitam Nutr Res 73 2003 411 415
298. P. Astorg, S. Gradelet, R. Berges, and M. Suschetet Dietary lycopene decreases the initiation of liver preneoplastic foci by diethylnitrosamine in the rat Nutr Cancer 29 1997 60 68
299. S. Gradelet, A.M. Le Bon, R. Berges, M. Suschetet, and P. Astorg Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism Carcinogenesis 19 1998 403 411
300. R.L. Sedjo, M.R. Papenfuss, N.E. Craft, and A.R. Giuliano Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States) Cancer Causes Control 14 2003 319 326
301. M.A. Beck, O.A. Levander, and J. Handy Selenium deficiency and viral infection J Nutr 133 2003 1463S 1467S
302. S.S. Hecht Inhibition of carcinogenesis by isothiocyanates Drug Metab Rev 32 2000 395 411
303. H. Steinkellner, S. Rabot, and C. Freywald Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens Mutat Res 2001 480 481 285-97
304. C. Zhu, H.E. Poulsen, and S. Loft Inhibition of oxidative DNA damage in vitro by extracts of brussels sprouts Free Radic Res 33 2000 187 196
305. O. Vang, H. Frandsen, K.T. Hansen, J.N. Sorensen, H. Sorensen, and O. Andersen Biochemical effects of dietary intakes of different broccoli samples I. Differential modulation of cytochrome P-450 activities in rat liver, kidney, and colon Metabolism 50 2001 1123 1129
306. J.D. Brooks, V.G. Paton, and G. Vidanes Potent induction of phase 2 enzymes in human prostate cells by sulforaphane Cancer Epidemiol Biomarkers Prev 10 2001 949 954
307. M.L. Clapper, C.E. Szarka, and G.R. Pfeiffer Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity Clin Cancer Res 3 1997 25 30
308. D.L. Lacey, E. Timms, and H.L. Tan Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 1998 165 176
309. H. Hsu, D.L. Lacey, and C.R. Dunstan Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand Proc Natl Acad Sci U S A 96 1999 3540 3545
310. Y. Wittrant, S. Theoleyre, S. Couillaud, C. Dunstan, D. Heymann, and F. Redini Regulation of osteoclast protease expression by RANKL Biochem Biophys Res Commun 310 2003 774 778
311. W.S. Simonet, D.L. Lacey, and C.R. Dunstan Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319
312. L.C. Hofbauer, and M. Schoppet Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases JAMA 292 2004 490 495
313. S. Theoleyre, Y. Wittrant, S.K. Tat, Y. Fortun, F. Redini, and D. Heymann The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling Cytokine Growth Factor Rev 15 2004 457 475
314. Y. Wittrant, S. Theoleyre, and C. Chipoy RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis Biochim Biophys Acta 1704 2004 49 57
315. G.R. Mundy Metastasis to bone: causes, consequences and therapeutic opportunities Nat Rev Cancer 2 2002 584 593
316. D. Goltzman Osteolysis and cancer J Clin Invest 107 2001 1219 1220
317. H. Yonou, N. Kanomata, and M. Goya Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice Cancer Res 63 2003 2096 2102
318. A. Crisafulli, D. Altavilla, and G. Squadrito Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women J Clin Endocrinol Metab 89 2004 188 192
319. P.V. Garcia, L.J. Robinson, C.W. Borysenko, T. Lehmann, S.E. Kalla, and H.C. Blair Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 Cells by estrogen and phytoestrogens J Biol Chem 280 2005 13720 13727
320. F.S. Poke, A. Qadi, and A.F. Holloway Reversing aberrant methylation patterns in cancer Curr Med Chem 17 2010 1246 1254
321. D.E. Matei, and K.P. Nephew Epigenetic therapies for chemoresensitization of epithelial ovarian cancer Gynecol Oncol 116 2010 195 201
322. N. Kikuno, H. Shiina, and S. Urakami Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells Int J Cancer 123 2008 552 560
323. S. Majid, A.A. Dar, and V. Shahryari Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer Cancer 116 2010 66 76
324. S. Saini, S. Majid, and R. Dahiya Diet, microRNAs and prostate cancer Pharm Res 27 2010 1014 1026
325. I.U. Ahmad, J.D. Forman, and F. Sarkar Reduction of adverse events by soy isoflavones in patients undergoing external beam radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 72 2008 S318
326. S.M. Lippman, and J.V. Heymach The convergent development of molecular-targeted drugs for cancer treatment and prevention Clin Cancer Res 13 2007 4035 4041